Eagle KA, Goodman SG, Avezum A., et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet2002 ;359:373-377.
2.
Simes RJ, Topol EJ, Holmes DR Jr, et al, for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation1995;91:1923-1928.
3.
Chesebro JH, Knatterud G., Roberts R., et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation1987;76:142-154.
4.
Fibrinolytic Therapy Trialists' (FTT)Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients . Lancet1994;343:311-322.
5.
Goswami NJ, Moody JM Jr, Bailey SRPercutaneous mechanical reperfusion during acute myocardial infarction . J Intensive Care Med2002;17:162-173.
6.
Hartzler GO, Rutherford BD, McConahay DR, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J1983;106:965-973.
7.
O'Neil W. , Timmis GC, Bourdillon PD, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplast for acute myocardial infarction. N Engl J med1986;812-818.
8.
Brodie BR, Stuckey TD, Wall TC, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol1998 ;32:1312-1319.
9.
Stone GW, Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the Primary Angioplasty in Myocardial Infarction trials. Circulation2001;104:636-641.
10.
Gibson CM, Cannon CP, Murphy SA, et al; for the TIMI (Thrombolysis In Myocardial Infarction) Study Group. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circ2000; 101(2):125-130.
11.
Ryan TJ, Antman EM, Brooks NH, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) . Circulation1999;100:1016-1030.
